More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif. , Nov. 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems.
SUNNYVALE, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Comprehensive Blood and Cancer Center (CBCC) -- one of the nation's largest freestanding, physician owned and operated comprehensive
New Unit Will Enable Italian Hospital to Expand Radiosurgery to Treat Lung and Prostate Cancer SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San Bortolo
Renowned Hospital in Turin, Italy Uses Innovative Radiation Therapy Delivery System to Expand Options for Advanced Cancer Care to More Patients SUNNYVALE, Calif. , Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments SUNNYVALE, Calif. , June 16, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a
First Government Contract Allows Greater Access to the Benefits of Radiosurgery SUNNYVALE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Government has purchased a CyberKnife(R) Robotic
UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif. , Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife®
Expands Patient Access to the Benefits of Whole Body Radiosurgery SUNNYVALE, Calif ., June 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Turkish Ministry of Health has purchased two CyberKnife(R) Robotic
SUNNYVALE, Calif. , Feb. 16, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative Evidence) indicates that stereotactic body radiation therapy (SBRT), in comparison to surgery,
- Accuray Precision™ Treatment Planning System and CyberKnife System Software Upgrade Enhances Efficiency and Ease-of-Use - Leading Radiation Oncology Providers at Institut Gustave Roussy, Lynn Cancer Institute, Multicare Hospital, Queen Elizabeth Hospital Birmingham, University Clinic for
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.